! The Capitol Complex is closed to the public due to COVID-19. All meetings will be held virtually online. View procedures and guidelines for remote public comment

Download Zipped Amended WordPerfect HB0190.ZIP
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 190

This document includes House Floor Amendments incorporated into the bill on Fri, Feb 23, 2007 at 9:10 AM by ddonat. -->              1     

CONTROLLED SUBSTANCE SCHEDULE

             2     
AMENDMENT

             3     
2007 GENERAL SESSION

             4     
STATE OF UTAH

             5     
Chief Sponsor: Paul Ray

             6     
Senate Sponsor: D. Chris Buttars

             7     
             8      LONG TITLE
             9      General Description:
             10          This bill modifies the Controlled Substances Act by adding salvia divinorum as a
             11      controlled substance.
             12      Highlighted Provisions:
             13          This bill:
             14          .    adds the herb salvia divinorum H. and salvinorin A, a psychoactive compound, .H
             14a      to the statutory list of controlled substances; and
             15          .    designates salvia divinorum H. and salvinorin A .H as H. [ a ] .H Schedule I
             15a      controlled H. [ substance ] substances .H .
             16      Monies Appropriated in this Bill:
             17          None
             18      Other Special Clauses:
             19          None
             20      Utah Code Sections Affected:
             21      AMENDS:
             22          58-37-4, as last amended by Chapter 8, Laws of Utah 2006
             23     
             24      Be it enacted by the Legislature of the state of Utah:
             25          Section 1. Section 58-37-4 is amended to read:
             26           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
             27      required -- Specific substances included in schedules.


             28          (1) There are established five schedules of controlled substances known as Schedules I,
             29      II, III, IV, and V which shall consist of substances listed in this section.
             30          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
             31      the official name, common or usual name, chemical name, or brand name designated:
             32          (a) Schedule I:
             33          (i) Unless specifically excepted or unless listed in another schedule, any of the
             34      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             35      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             36      chemical designation:
             37          (A) Acetyl-alpha-methylfentanyl
             38      (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
             39          (B) Acetylmethadol;
             40          (C) Allylprodine;
             41          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             42      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             43          (E) Alphameprodine;
             44          (F) Alphamethadol;
             45          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             46      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
             47          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             48      piperidinyl]-N-phenylpropanamide);
             49          (I) Benzethidine;
             50          (J) Betacetylmethadol;
             51          (K) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             52      piperidinyl]-N-phenylpropanamide);
             53          (L) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
             54      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             55          (M) Betameprodine;
             56          (N) Betamethadol;
             57          (O) Betaprodine;
             58          (P) Clonitazene;


             59          (Q) Dextromoramide;
             60          (R) Diampromide;
             61          (S) Diethylthiambutene;
             62          (T) Difenoxin;
             63          (U) Dimenoxadol;
             64          (V) Dimepheptanol;
             65          (W) Dimethylthiambutene;
             66          (X) Dioxaphetyl butyrate;
             67          (Y) Dipipanone;
             68          (Z) Ethylmethylthiambutene;
             69          (AA) Etonitazene;
             70          (BB) Etoxeridine;
             71          (CC) Furethidine;
             72          (DD) Hydroxypethidine;
             73          (EE) Ketobemidone;
             74          (FF) Levomoramide;
             75          (GG) Levophenacylmorphan;
             76          (HH) Morpheridine;
             77          (II) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             78          (JJ) Noracymethadol;
             79          (KK) Norlevorphanol;
             80          (LL) Normethadone;
             81          (MM) Norpipanone;
             82          (NN) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
             83      propanamide;
             84          (OO) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
             85          (PP) Phenadoxone;
             86          (QQ) Phenampromide;
             87          (RR) Phenomorphan;
             88          (SS) Phenoperidine;
             89          (TT) Piritramide;


             90          (UU) Proheptazine;
             91          (VV) Properidine;
             92          (WW) Propiram;
             93          (XX) Racemoramide;
             94          (YY) Salvia divinorum;
             94a           H. (ZZ) Salvinorin A; .H
             95          [(YY)] H. [ (ZZ) ] (AAA) .H Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
             96      propanamide;
             97          [(ZZ)] H. [ (AAA) ] (BBB) .H Tilidine;
             98          [(AAA)] H. [ (BBB) ] (CCC) .H Trimeperidine;
             99          [(BBB)] H. [ (CCC) ] (DDD) .H 3-methylfentanyl, including the optical and geometric
             99a      isomers
             100      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             101          [(CCC)] H. [ (DDD) ] (EEE) .H 3-methylthiofentanyl
             102      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             103          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             104      following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
             105      salts, isomers, and salts of isomers is possible within the specific chemical designation:
             106          (A) Acetorphine;
             107          (B) Acetyldihydrocodeine;
             108          (C) Benzylmorphine;
             109          (D) Codeine methylbromide;
             110          (E) Codeine-N-Oxide;
             111          (F) Cyprenorphine;
             112          (G) Desomorphine;
             113          (H) Dihydromorphine;
             114          (I) Drotebanol;
             115          (J) Etorphine (except hydrochloride salt);
             116          (K) Heroin;
             117          (L) Hydromorphinol;
             118          (M) Methyldesorphine;
             119          (N) Methylhydromorphine;
             120          (O) Morphine methylbromide;


             121          (P) Morphine methylsulfonate;
             122          (Q) Morphine-N-Oxide;
             123          (R) Myrophine;
             124          (S) Nicocodeine;
             125          (T) Nicomorphine;
             126          (U) Normorphine;
             127          (V) Pholcodine; and
             128          (W) Thebacon.
             129          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             130      compound, mixture, or preparation which contains any quantity of the following hallucinogenic
             131      substances, or which contains any of their salts, isomers, and salts of isomers when the
             132      existence of the salts, isomers, and salts of isomers is possible within the specific chemical
             133      designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
             134      geometric isomers:
             135          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             136      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             137          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             138      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             139          (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
             140      2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
             141          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             142      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             143          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             144          (F) 4-methoxyamphetamine, some trade or other names:
             145      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             146          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             147          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
             148      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
             149          (I) 3,4-methylenedioxy amphetamine;
             150          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             151          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-


             152      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             153          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
             154      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             155          (M) 3,4,5-trimethoxy amphetamine;
             156          (N) Bufotenine, some trade and other names:
             157      3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
             158      N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
             159          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             160          (P) Dimethyltryptamine, some trade or other names: DMT;
             161          (Q) Ibogaine, some trade and other names:
             162      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             163      [5,4-b] indole; Tabernanthe iboga;
             164          (R) Lysergic acid diethylamide;
             165          (S) Marijuana;
             166          (T) Mescaline;
             167          (U) Parahexyl, some trade or other names:
             168      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             169          (V) Peyote, meaning all parts of the plant presently classified botanically as
             170      Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
             171      any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
             172      preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             173          (W) N-ethyl-3-piperidyl benzilate;
             174          (X) N-methyl-3-piperidyl benzilate;
             175          (Y) Psilocybin;
             176          (Z) Psilocyn;
             177          (AA) Tetrahydrocannabinols, synthetic equivalents of the substances contained in the
             178      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
             179      and their isomers with similar chemical structure and pharmacological activity such as the
             180      following: .1 cis or trans tetrahydrocannabinol, and their optical isomers .6 cis or trans
             181      tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its
             182      optical isomers, and since nomenclature of these substances is not internationally standardized,


             183      compounds of these structures, regardless of numerical designation of atomic positions
             184      covered;
             185          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             186      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             187      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             188          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             189      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             190          (DD) Thiophene analog of phencyclidine, some trade or other names:
             191      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             192          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
             193          (iv) Unless specifically excepted or unless listed in another schedule, any material
             194      compound, mixture, or preparation which contains any quantity of the following substances
             195      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             196      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             197      specific chemical designation:
             198          (A) Mecloqualone; and
             199          (B) Methaqualone.
             200          (v) Any material, compound, mixture, or preparation containing any quantity of the
             201      following substances having a stimulant effect on the central nervous system, including their
             202      salts, isomers, and salts of isomers:
             203          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             204      4,5-dihydro-5-phenyl-2-oxazolamine;
             205          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
             206      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             207          (C) Fenethylline;
             208          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
             209      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             210      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
             211      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             212      optical isomers;
             213          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);


             214          (F) N-ethylamphetamine; and
             215          (G) N,N-dimethylamphetamine, also known as
             216      N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
             217          (vi) Any material, compound, mixture, or preparation which contains any quantity of
             218      the following substances, including their optical isomers, salts, and salts of isomers, subject to
             219      temporary emergency scheduling:
             220          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             221          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             222          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             223      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
             224      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             225          (b) Schedule II:
             226          (i) Unless specifically excepted or unless listed in another schedule, any of the
             227      following substances whether produced directly or indirectly by extraction from substances of
             228      vegetable origin, or independently by means of chemical synthesis, or by a combination of
             229      extraction and chemical synthesis:
             230          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             231      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             232      and their respective salts, but including:
             233          (I) Raw opium;
             234          (II) Opium extracts;
             235          (III) Opium fluid;
             236          (IV) Powdered opium;
             237          (V) Granulated opium;
             238          (VI) Tincture of opium;
             239          (VII) Codeine;
             240          (VIII) Ethylmorphine;
             241          (IX) Etorphine hydrochloride;
             242          (X) Hydrocodone;
             243          (XI) Hydromorphone;
             244          (XII) Metopon;


             245          (XIII) Morphine;
             246          (XIV) Oxycodone;
             247          (XV) Oxymorphone; and
             248          (XVI) Thebaine;
             249          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             250      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             251      substances may not include the isoquinoline alkaloids of opium;
             252          (C) Opium poppy and poppy straw;
             253          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
             254      any salt, compound, derivative, or preparation which is chemically equivalent or identical with
             255      any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
             256      and salts of isomers and derivatives, whether derived from the coca plant or synthetically
             257      produced, except the substances may not include decocainized coca leaves or extraction of coca
             258      leaves, which extractions do not contain cocaine or ecgonine; and
             259          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             260      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             261          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             262      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             263      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             264      chemical designation, except dextrorphan and levopropoxyphene:
             265          (A) Alfentanil;
             266          (B) Alphaprodine;
             267          (C) Anileridine;
             268          (D) Bezitramide;
             269          (E) Bulk dextropropoxyphene (nondosage forms);
             270          (F) Carfentanil;
             271          (G) Dihydrocodeine;
             272          (H) Diphenoxylate;
             273          (I) Fentanyl;
             274          (J) Isomethadone;
             275          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,


             276      levomethadyl acetate, or LAAM;
             277          (L) Levomethorphan;
             278          (M) Levorphanol;
             279          (N) Metazocine;
             280          (O) Methadone;
             281          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             282          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             283      acid;
             284          (R) Pethidine (meperidine);
             285          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
             286          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             287          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             288          (V) Phenazocine;
             289          (W) Piminodine;
             290          (X) Racemethorphan;
             291          (Y) Racemorphan;
             292          (Z) Remifentanil; and
             293          (AA) Sufentanil.
             294          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             295      compound, mixture, or preparation which contains any quantity of the following substances
             296      having a stimulant effect on the central nervous system:
             297          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             298          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
             299          (C) Phenmetrazine and its salts; and
             300          (D) Methylphenidate.
             301          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             302      compound, mixture, or preparation which contains any quantity of the following substances
             303      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             304      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             305      specific chemical designation:
             306          (A) Amobarbital;


             307          (B) Glutethimide;
             308          (C) Pentobarbital;
             309          (D) Phencyclidine;
             310          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             311      1-piperidinocyclohexanecarbonitrile (PCC); and
             312          (F) Secobarbital.
             313          (v) Unless specifically excepted or unless listed in another schedule, any material,
             314      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             315          Some of these substances may be known by trade or other names: phenyl-2-propanone,
             316      P2P; benzyl methyl ketone, methyl benzyl ketone.
             317          (vi) Nabilone, another name for nabilone:
             318      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             319      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             320          (c) Schedule III:
             321          (i) Unless specifically excepted or unless listed in another schedule, any material,
             322      compound, mixture, or preparation which contains any quantity of the following substances
             323      having a stimulant effect on the central nervous system, including its salts, isomers whether
             324      optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
             325      and salts of isomers is possible within the specific chemical designation:
             326          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             327      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
             328      listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
             329      Code of Federal Regulations, and any other drug of the quantitive composition shown in that
             330      list for those drugs or which is the same except that it contains a lesser quantity of controlled
             331      substances;
             332          (B) Benzphetamine;
             333          (C) Chlorphentermine;
             334          (D) Clortermine; and
             335          (E) Phendimetrazine.
             336          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             337      compound, mixture, or preparation which contains any quantity of the following substances


             338      having a depressant effect on the central nervous system:
             339          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
             340      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
             341      which are not listed in any schedule;
             342          (B) Any suppository dosage form containing amobarbital, secobarbital, or
             343      pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
             344      Administration for marketing only as a suppository;
             345          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
             346      salt of any of them;
             347          (D) Chlorhexadol;
             348          (E) Buprenorphine;
             349          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
             350      isomers, and salts of isomers, for which an application is approved under the federal Food,
             351      Drug, and Cosmetic Act, Section 505;
             352          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
             353      . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
             354          (H) Lysergic acid;
             355          (I) Lysergic acid amide;
             356          (J) Methyprylon;
             357          (K) Sulfondiethylmethane;
             358          (L) Sulfonethylmethane;
             359          (M) Sulfonmethane; and
             360          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
             361      tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             362      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             363      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
             364      flupyrazapon.
             365          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
             366      U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             367      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
             368      (-)-delta-9-(trans)-tetrahydrocannabinol.


             369          (iv) Nalorphine.
             370          (v) Unless specifically excepted or unless listed in another schedule, any material,
             371      compound, mixture, or preparation containing limited quantities of any of the following
             372      narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
             373          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             374      milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
             375      opium;
             376          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             377      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             378      therapeutic amounts;
             379          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             380      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
             381      alkaloid of opium;
             382          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             383      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             384      recognized therapeutic amounts;
             385          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             386      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             387      therapeutic amounts;
             388          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
             389      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             390      recognized therapeutic amounts;
             391          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
             392      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             393      recognized therapeutic amounts; and
             394          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
             395      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             396          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
             397      including any of the following or any isomer, ester, salt, or derivative of the following that
             398      promotes muscle growth:
             399          (A) Boldenone;


             400          (B) Chlorotestosterone (4-chlortestosterone);
             401          (C) Clostebol;
             402          (D) Dehydrochlormethyltestosterone;
             403          (E) Dihydrotestosterone (4-dihydrotestosterone);
             404          (F) Drostanolone;
             405          (G) Ethylestrenol;
             406          (H) Fluoxymesterone;
             407          (I) Formebulone (formebolone);
             408          (J) Mesterolone;
             409          (K) Methandienone;
             410          (L) Methandranone;
             411          (M) Methandriol;
             412          (N) Methandrostenolone;
             413          (O) Methenolone;
             414          (P) Methyltestosterone;
             415          (Q) Mibolerone;
             416          (R) Nandrolone;
             417          (S) Norethandrolone;
             418          (T) Oxandrolone;
             419          (U) Oxymesterone;
             420          (V) Oxymetholone;
             421          (W) Stanolone;
             422          (X) Stanozolol;
             423          (Y) Testolactone;
             424          (Z) Testosterone; and
             425          (AA) Trenbolone.
             426          Anabolic steroids expressly intended for administration through implants to cattle or
             427      other nonhuman species, and approved by the Secretary of Health and Human Services for use,
             428      may not be classified as a controlled substance.
             429          (d) Schedule IV:
             430          (i) Unless specifically excepted or unless listed in another schedule, any material,


             431      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
             432      less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
             433          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             434      compound, mixture, or preparation which contains any quantity of the following substances,
             435      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
             436      salts of isomers is possible within the specific chemical designation:
             437          (A) Alprazolam;
             438          (B) Barbital;
             439          (C) Bromazepam;
             440          (D) Butorphanol;
             441          (E) Camazepam;
             442          (F) Chloral betaine;
             443          (G) Chloral hydrate;
             444          (H) Chlordiazepoxide;
             445          (I) Clobazam;
             446          (J) Clonazepam;
             447          (K) Clorazepate;
             448          (L) Clotiazepam;
             449          (M) Cloxazolam;
             450          (N) Delorazepam;
             451          (O) Diazepam;
             452          (P) Dichloralphenazone;
             453          (Q) Estazolam;
             454          (R) Ethchlorvynol;
             455          (S) Ethinamate;
             456          (T) Ethyl loflazepate;
             457          (U) Fludiazepam;
             458          (V) Flunitrazepam;
             459          (W) Flurazepam;
             460          (X) Halazepam;
             461          (Y) Haloxazolam;


             462          (Z) Ketazolam;
             463          (AA) Loprazolam;
             464          (BB) Lorazepam;
             465          (CC) Lormetazepam;
             466          (DD) Mebutamate;
             467          (EE) Medazepam;
             468          (FF) Meprobamate;
             469          (GG) Methohexital;
             470          (HH) Methylphenobarbital (mephobarbital);
             471          (II) Midazolam;
             472          (JJ) Nimetazepam;
             473          (KK) Nitrazepam;
             474          (LL) Nordiazepam;
             475          (MM) Oxazepam;
             476          (NN) Oxazolam;
             477          (OO) Paraldehyde;
             478          (PP) Pentazocine;
             479          (QQ) Petrichloral;
             480          (RR) Phenobarbital;
             481          (SS) Pinazepam;
             482          (TT) Prazepam;
             483          (UU) Quazepam;
             484          (VV) Temazepam;
             485          (WW) Tetrazepam;
             486          (XX) Triazolam;
             487          (YY) Zaleplon; and
             488          (ZZ) Zolpidem.
             489          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
             490      any quantity of the following substances, including its salts, isomers whether optical, position,
             491      or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
             492      isomers is possible.


             493          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             494      compound, mixture, or preparation which contains any quantity of the following substances
             495      having a stimulant effect on the central nervous system, including its salts, isomers whether
             496      optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
             497      isomers, and salts of isomers is possible within the specific chemical designation:
             498          (A) Cathine ((+)-norpseudoephedrine);
             499          (B) Diethylpropion;
             500          (C) Fencamfamine;
             501          (D) Fenproprex;
             502          (E) Mazindol;
             503          (F) Mefenorex;
             504          (G) Modafinil;
             505          (H) Pemoline, including organometallic complexes and chelates thereof;
             506          (I) Phentermine;
             507          (J) Pipradrol;
             508          (K) Sibutramine; and
             509          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             510          (v) Unless specifically excepted or unless listed in another schedule, any material,
             511      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             512      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
             513          (e) Schedule V: Any compound, mixture, or preparation containing any of the
             514      following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
             515      base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
             516      sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
             517      qualities other than those possessed by the narcotic drug alone:
             518          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             519          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
             520      grams;
             521          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
             522      grams;
             523          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of


             524      atropine sulfate per dosage unit;
             525          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             526          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
             527      atropine sulfate per dosage unit; and
             528          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             529      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
             530      effect on the central nervous system, including its salts, isomers, and salts of isomers.




Legislative Review Note
    as of 1-18-07 8:06 AM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]